Cite
HARVARD Citation
Hahn, K. et al. (2015). Treatment With Anakinra, a Recombinant IL‐1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis. American journal of gastroenterology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hahn, K. et al. (2015). Treatment With Anakinra, a Recombinant IL‐1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis. American journal of gastroenterology. p. . [Online].